AMT, INC.

Company Information
Address 508 HEARTWOOD RD
CHERRY HILL, NJ 08003
CHERRY HILL, NJ, 08003


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. ENDOSCOPIC LIGHT SOURCE FOR PDT

    Amount: $278,132.00

    DESCRIPTION (Verbatim from the Applicant's Abstract): We propose to continue to develop and test a self-contained light delivery device for use in photodynamic therapy (PDT) for Barrett's es ...

    STTRPhase II2001Department of Health and Human Services
  2. ENDOSCOPIC LIGHT SOURCE FOR PDT

    Amount: $0.00

    DESCRIPTION (Verbatim from the Applicant's Abstract): We propose to continue to develop and test a self-contained light delivery device for use in photodynamic therapy (PDT) for Barrett's es ...

    STTRPhase I2001Department of Health and Human Services
  3. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  4. THERMODILUTION RIGHT VENTRICULAR EJECTION FRACTION

    Amount: $100,000.00

    N/A

    STTRPhase I1999Department of Health and Human Services
  5. MICROWAVE AIDED LIPOSUCTION

    Amount: $100,000.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
  6. POLYMERIC DELIVERY SYSTEMS FOR ANTIRETROVIRAL AGENTS

    Amount: $49,855.00

    THE GOAL OF THIS PHASE I RESEARCH IS TO DESIGN, SYNTHESIZE, DEVELOP, AND EVALUATE THE IN VITRO EFFICACY OF A NEW CLASS OF POLYMERIC "TARGETED" PRODRUGS OF AZT. THE OVERALL OBJECTIVE OF THIS PROGRAM IS ...

    SBIRPhase I1990Department of Health and Human Services
  7. SOLUBILIZATION AND SUSTAINED DELIVERY OF ANTITUMOR AGENTS

    Amount: $49,838.00

    THE OVERALL OBJECTIVE IS TO PROVIDE A NEW DRUG DELIVERY SYSTEM AND TO ENHANCE THE SOLUBILITY OF EXISTING COMPOUNDS THAT EXHIBIT EXCELLENT ANTITUMOR PROPERTIES BUT ARE INSOLUBLE IN WATER. AQUEOUS SOLUB ...

    SBIRPhase I1990Department of Health and Human Services
  8. NEW TARGET-DIRECTED PT-PORPHYRIN ANTICANCER DRUGS

    Amount: $46,000.00

    THE OBJECTIVE OF THIS PROJECT IS TO IMPROVE THE SELECTIVITY OF ACTION OF PLATINUM ANTITUMOR AGENTS. PLATINUM COMPOUNDS HAVE SHOWN ACTIVITY IN MANY TYPES OF TUMORS, BUT SEVERE DOSE-LIMITING SIDE EFFECT ...

    SBIRPhase I1987Department of Health and Human Services
  9. MECHANISM-BASED ELASTASE INHIBITORS

    Amount: $50,000.00

    SYNTHETIC ELASTASE INHIBITORS FOR USE IN THE TREATMENT OF EMPHYSEMA WILL BE DEVELOPED. IN PHASE I, NEW MECHANISM-BASED ELASTASE INHIBITORS WILL BE SYNTHESIZED, CHARACTERIZED, AND STUDIED AS INHIBITORS ...

    SBIRPhase I1987Department of Health and Human Services
  10. THE COMPLEX 4-CARBOXYPHTHALATO (1, 2-DIAMINOCYCLOHEXANE) PLATINUM (NSC 271674; DACH-PT) HAS UNDERGONE LIMITED CLINICAL TRIALS.

    Amount: $50,000.00

    THE COMPLEX 4-CARBOXYPHTHALATO (1, 2-DIAMINOCYCLOHEXANE) PLATINUM (NSC 271674; DACH-PT) HAS UNDERGONE LIMITED CLINICAL TRIALS. DESIGNED AS AN ALTERNATIVE THERAPY TO CISPLATIN, IT HAS DEMONSTRATED SUBS ...

    SBIRPhase I1986Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government